Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianmarco Abbadessa

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|January 22, 2022
Hemostasis Components as Therapeutic Targets in Autoimmune DemyelinationGianmarco Abbadessa, Caterina Mainero, Simona Bonavita
Journal of Neurology|August 16, 2025
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosisGianmarco Abbadessa, Elisabetta Maida, Simona Bonavita, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2023
Viral pericarditis following ocrelizumab in a multiple sclerosis patientGiuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 12, 2022
Emotional facial palsy: an unusual and rarely explored neurological signGiuseppina Miele, Luigi Lavorgna, Maria Maddalena Marrapodi, et al.
Expert Review of Neurotherapeutics|July 19, 2021
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosisGianmarco Abbadessa, Luigi Lavorgna, Francesca Trojsi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 29, 2022
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemicMaddalena Sparaco, Giuseppina Miele, Luigi Lavorgna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 19, 2021
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosisGianmarco Abbadessa, Luigi Lavorgna, Constantina Andrada Treaba, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 22, 2023
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profilesLorenzo Cipriano, Giuseppina Miele, Lorenzo Ugga, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2020
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tailAlessandro Bombaci, Gianmarco Abbadessa, Francesca Trojsi, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic reviewGianmarco Abbadessa, Giuseppina Miele, Elisabetta Maida, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|January 22, 2022
Hemostasis Components as Therapeutic Targets in Autoimmune DemyelinationGianmarco Abbadessa, Caterina Mainero, Simona Bonavita
Journal of Neurology|August 16, 2025
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosisGianmarco Abbadessa, Elisabetta Maida, Simona Bonavita, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2023
Viral pericarditis following ocrelizumab in a multiple sclerosis patientGiuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 12, 2022
Emotional facial palsy: an unusual and rarely explored neurological signGiuseppina Miele, Luigi Lavorgna, Maria Maddalena Marrapodi, et al.
Expert Review of Neurotherapeutics|July 19, 2021
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosisGianmarco Abbadessa, Luigi Lavorgna, Francesca Trojsi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 29, 2022
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemicMaddalena Sparaco, Giuseppina Miele, Luigi Lavorgna, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 19, 2021
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosisGianmarco Abbadessa, Luigi Lavorgna, Constantina Andrada Treaba, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 22, 2023
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profilesLorenzo Cipriano, Giuseppina Miele, Lorenzo Ugga, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2020
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tailAlessandro Bombaci, Gianmarco Abbadessa, Francesca Trojsi, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic reviewGianmarco Abbadessa, Giuseppina Miele, Elisabetta Maida, et al.
Pageof 7